The YUMAB® platform provides all technologies for a fully integrated human antibody development in one company. We offer individually designed, work package-based contract research projects – from your target molecule to your engineered and optimized antibody lead candidate. Single technology modules or combinations thereof are also available as R&D service to assist your antibody program at every stage.
The YUMAB® platform includes three core technologies:
- Hit Discovery: Generation of unique specific antibody hits for your target structure that bind in your designated assay.
- Lead Engineering: Optimization of selected antibody hits with the most promising binding characteristics with respect to affinity, specificity, selectivity or stability into early antibody lead candidates.
- Lead Development: Identification of the most developable early lead candidates and final polishing of the antibody sequences to your final lead candidate(s) for cell line development.
Contact
YUMAB GMBH
Science Campus Braunschweig-Süd
Inhoffenstr. 7
38124 Braunschweig – Germany
Email: info@yumab.com
Phone: +49 531 481170-0
YUMAB GmbH
Science Campus Braunschweig-Süd
Inhoffenstr. 7
38124 Braunschweig – Germany
Phone: +49 531 481170-0
Fax: +49-531 481170-17
